top of page

hemotune raises CHF 5.1 million Series A funding

hemotune AG, currently incubated at Wyss Zurich, today announced the closing of a CHF 5.1 million Series A to advance the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads. Despite the corona crisis, hemotune managed to build a very strong consortium led by OCCIDENT with participation of the Korean medical device company Green Cross Medical Science Corp. (GCMS), and Zürcher Kantonalbank.

Click on the link below to read the full press release:

Featured Posts
Recent Posts
bottom of page